I've got a smidge of money in Editas, and it's sat there like a turtle for three or four years. But all of a sudden this week it's skyrocketing. Apparently they're going into clinical trials for gene editing sickle cell anemia into submission.
https://www.fool.com/investing/2020/...eting-for-the/
I don't know if it's too late to get in, but I suspect it's got more positive momentum. It's gone up almost exactly 100 percent in the past seven days.